Dr. Hira Khalid
Associate Professor
Department of Chemistry
Extension Number:
Office Number:
Brief Profile
Dr. Hira Khalid is an Associate Professor at Forman Christian College University’s Department of Chemistry. An experienced researcher in organic synthesis and medicinal chemistry, Dr. Hira has made significant contributions to drug design and development aimed at enhancing the health industry’s standards and improving quality of life. She holds a PhD in Chemistry from GC University Lahore, Pakistan in collaboration with University of Washington Seattle, USA. Her research primarily focuses on synthesizing and evaluating novel chemical entities for potential therapeutic applications which include cancer, Alzheimer, Infectious diseases i.e HCV and antileishmanial. She has published over forty research articles in international journals including Nature Communications, ACS Journal of medicinal Chemistry, RSC Advances. She is author of Elsevier bock chapter “Emerging Trends in Chemical Sciences”.
Education
⦁ Post-Doc (US Fulbright Scholar) in Medicinal Chemistry, University of Minnesota Twin Cities, Minneapolis, USA
⦁ PhD Chemistry (HEC Indigenous scholarship & IRSIP Awardee) with specialization in Synthetic Organic and Medicinal Chemistry, GC University Lahore Pakistan in collaboration with University of Washington Seattle, USA
⦁ MS Chemistry with specialization in Analytical Chemistry, University of the Punjab, Lahore Pakistan
⦁ BSc Hons. in Chemistry, University of the Punjab, Lahore Pakistan
Research & Publications
Dr. Hira’s research has led to the discovery and development of small molecules drug contenders for the Cancer, HCV, Alzheimer, Microbial infections. Her work has been published extensively in reputable scientific journals and she has been involved in numerous international collaborations that emphasize the synthesis and biological evaluation of medicinal compounds. Her recent projects include the design and synthesis of novel small molecule inhibitors for ovarian cancer treatment, selected in Phase I of Women in Science Program. She has awarded IRIF grants for her projects focusing on synthesis of heterocyclic polyfunctional compounds as potential anticancer agents and Design and synthesis of HCV-NS3 protease inhibitors. She is HEC approved Research supervisor. Dr. Hira is member of prestigious professional societies ACS, RSC, IUPAC, CSP and advisor ACS Punjab.
Selected Publications:
⦁ Muhammad Nawaz Shah, Hira Khalid*, Sabina Jhaumeer Laulloo, Nausheen Joondan, Muhammad Nadeem Arshad, Abdullah M. Asiri, Hassan Butt “Synthesis, Characterization, and BSA Binding studies of Newfangled 2-Phenylacetohydrazide derivatives” Heliyon, 2024, HELIYON-D-22-31658, Accepted. https://doi.org/10.1016/j.heliyon.2024.e27303
⦁ Rashid Hussain, Zulkarnain Haider, Hira Khalid*, Qaiser Fatmi, Simone Carradori, Amelia Cataldi and Susi Zara “Computational medicinal chemistry applications to target Asian-prevalent strain of hepatitis C virus” RSC Advances, 13, 30052 2023, https://doi.org/10.1039/D3RA04622B
⦁ Erik B. Faber, Jian Tang, Emily Roberts, Sornakala Ganeshkumar, Luxin Sun, Nan Wang, Damien Rasmussen, Abir Majumdar, Kristen John, An Yang, Hira Khalid, Jon E.Hawkinson, Nicholas M. Levinson, Ernst Schönbrunn, Vargheese Chennathukuzhi, Daniel A. Harki, Gunda I. Georg “Allosteric, selective cyclin-dependent kinase 2 inhibitors are negatively cooperative with cyclin binding and show potential as contraceptive agents” Nature Communications, 14, 3213, 1-13 2023 https://doi.org/10.1038/s41467-023-38732-x.
⦁ Erik B. Faber, Nan Wang, Kristen John, Luxin Sun, David Burban, Henry Wong, Rawle, Francis, Defeng Tian, Kwon H. Hong, Liming Wang, An Yang, Mazen Elsaid, Jian Tang, Emily Roberts, Sornakala Ganeshkumar, Damien Rasmussen, Abir Majumdar, Hira Khalid, Nicholas M. Levinson, Ernst Schönbrunn, Jon E.Hawkinson, Gunda I. Georg “The discovery of high affinity and metabolically stable allosteric cyclin-dependent kinase 2 (CDK2) inhibitors from screening through lead optimization” ACS Journal of Medicinal Chemistry, 66, 3, 1928–1940 2023 https://doi.org/10.1021/acs.jmedchem.2c01731.
⦁ Hira Khalid, Aziz-ur-Rehman, M. Athar Abbasi, Abdul Malik, Shahid Rasool, Khadija Nafeesa, Irshad Ahmad, Saira Afzal, ”Synthesis, spectral analysis and anti-bacterial study of N-substituted derivatives of 2-(5-(1(phenylsulfonyl)piperidin-4-yl)-1,3,4-oxadiazol2-ylthio)acetamide, Journal of Saudi Chemical Society, Vol 20, S615–S623, 2016 https://doi.org/10.1016/j.jscs.2013.05.001